ETSY · Etsy Inc · Insider Trading

These sales were made pursuant to an Rule 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.73 to $83.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

These stock options are part of a grant that vested as to 25% on May 4, 2018 with the remainder vesting in 36 equal monthly installments.

These sales were made pursuant to an Rule 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.93 to $84.475, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These sales were made pursuant to an Rule 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.70 to $82.425, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.61 to $82.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Represents restricted stock units which correspond 1-for-1 with common stock.

The restricted stock units vest in 16 equal quarterly installments, beginning on September 1, 2025, provided the Reporting Person remains continuously employed on, or becomes retirement eligible prior to, such vesting date.

Shares of common stock acquired upon the vesting of restricted stock units.

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.77 to $82.675, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.71 to $81.685, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.61 to $81.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

These stock options are part of a grant that vested as to 25% on May 4, 2018 with the remainder vesting in 36 equal monthly installments.

These shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025.

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $78.71 to $79.795 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

These sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $78.71 to $79.53 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $79.76 to $80.16 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025.

These shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025.

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $79.87 to $79.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This exercise and subsequent sales were made pursuant to an Rule 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

The shares underlying these stock options are fully exercisable.

This exercise and subsequent sales were made pursuant to an Rule 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.555 to $81.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This exercise and subsequent sales were made pursuant to an Rule 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.63 to $83.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This exercise and subsequent sales were made pursuant to an Rule 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.59 to $82.435, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This exercise and subsequent sales were made pursuant to an Rule 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.91 to $84.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This exercise and subsequent sales were made pursuant to an Rule 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.53 to $86.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.00 to $84.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

These stock options are part of a grant that vested as to 25% on May 4, 2018 with the remainder vesting in 36 equal monthly installments.

These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.47 to $86.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.02 to $83.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This exercise and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

This exercise and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.92 to $82.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2026.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.02 to $82.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This exercise and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.95 to $83.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Reflects the transfer of 109,675 shares previously held by the Reporting Person's grantor retained annuity trust to the Reporting Person's direct ownership on July 17, 2026. This transfer is exempt from Section 16 pursuant to Rule 16a-13.

This exercise and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

These stock options are part of a grant that vested as to 25% on May 4, 2018 with the remainder vesting in 36 equal monthly installments.

Shares of common stock acquired upon the vesting of restricted stock units.

Represents restricted stock units which correspond 1-for-1 with common stock.

25% of the restricted stock units vested on February 1, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, provided the Reporting Person remains continuously employed on each vesting date.

This transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2025

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

These stock options are part of a grant that vested as to 25% on May 4, 2018 with the remainder vesting in 36 equal monthly installments.

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2025

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2025

The option was fully vested and immediately exercisable.

This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

This exercise and subsequent sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2025.

These stock options are part of a grant that vested as to 25% on May 4, 2018 with the remainder vesting in 36 equal monthly installments.